Healthcare Services

Rising Thyroid Cancer Cases Driving Growth in the Diagnostics Market

April 28, 2026April 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Thyroid Cancer Diagnostics Market Be By 2030 Compared To Its 2026 Market Size?

The thyroid cancer diagnostics market has experienced robust expansion in recent years. This market is projected to grow from $3.15 billion in 2025 to $3.34 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.0%. The growth observed in the historical period can be attributed to the increasing incidence of thyroid nodules, broader availability of ultrasound imaging, advancements in biopsy techniques, the proliferation of cancer diagnostic laboratories, and enhanced clinical awareness of thyroid cancers.

Significant expansion is anticipated for the thyroid cancer diagnostics market size over the coming years. This market is projected to reach $4.25 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.2%. Factors contributing to this growth during the forecast period include the increasing uptake of AI-assisted imaging diagnostics, a surging demand for personalized oncology diagnostics, the broadening of molecular testing panels, increasing investments in early cancer screening initiatives, and a heightened emphasis on precision diagnostics. Key trends expected throughout the forecast period encompass the escalating utilization of molecular diagnostic techniques, the growing embrace of imaging-based screening methods, the expanding integration of genetic testing, the enlargement of early detection programs, and improvements in both diagnostic accuracy and speed.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12030&type=smp

What Key Factors Are Shaping The Thyroid Cancer Diagnostics Market Landscape?

The rising incidence of thyroid cancer is fueling the expansion of the thyroid cancer diagnostic market moving forward. Thyroid cancer refers to a condition affecting the thyroid gland, which is situated near the base of the throat and produces hormones vital for regulating body temperature, heart rate, blood pressure, and weight. Thyroid cancer diagnostics play a crucial role in identifying this cancer through early detection, which can significantly enhance treatment outcomes. Consequently, the growing occurrence of thyroid cancer boosts the demand for the diagnostic market. For instance, a report published by the American Cancer Society, a US-based non-profit organization, in September 2023, estimated approximately 43,720 new cases of thyroid cancer in 2023, comprising 12,540 cases in men and 31,180 in women. The projected number of deaths from thyroid cancer in the same year is around 2,120, with 970 among men and 1,150 among women. Hence, the increasing prevalence of thyroid cancer is propelling the thyroid cancer diagnostic market.

What Are The Key Segment Divisions In The Thyroid Cancer Diagnostics Market Segment Structure?

The thyroid cancer diagnostics market covered in this report is segmented –

1) By Technique Type: Imaging Test, Blood Test, Biopsy, Other Test Types

2) By Disease Type: Papillary Carcinoma, Follicular Carcinoma, Other Diseases

3) By End-User: Hospital Laboratories, Cancer Diagnostic Centers, Research Institutes, Other End-Users

Subsegments:

1) By Imaging Test: Ultrasound Imaging, Computed Tomography (CT) Scans, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) Scans, Radioactive Iodine Scans

2) By Blood Test: Thyroid Function Tests, Tumor Marker Tests, Genetic Testing For Thyroid Cancer

3) By Biopsy: Fine Needle Aspiration (FNA) Biopsy, Core Needle Biopsy, Surgical Biopsy

4) By Other Test Type: Molecular Diagnostics, Immunohistochemistry Tests, Histopathological Analysis

What Market Trends Are Affecting The Thyroid Cancer Diagnostics Market?

Major companies operating in the thyroid cancer diagnostic market are developing innovative solutions, such as RNA sequencing tests, to enhance the accuracy of cancer fusion detection across multiple solid tumors, including thyroid cancer. RNA sequencing (RNA-Seq) is a high-throughput technique that allows for the analysis of the quantity and sequence of RNA in a sample, providing insights into gene expression and the overall transcriptome. For instance, in May 2024, Foundation Medicine, Inc., a US-based biotechnology company, announced the U.S. launch of FoundationOne RNA, a tissue-based RNA sequencing test designed to detect cancer-related gene fusions across 318 genes. This test provides fusion reporting for all solid tumors and may be particularly useful in identifying fusions in cancers like non-small cell lung cancer (NSCLC), sarcoma, pancreatic cancer, thyroid cancer, cholangiocarcinoma, and bladder cancer.

Which Organizations Are Engaged In The Thyroid Cancer Diagnostics Market?

Major companies operating in the thyroid cancer diagnostics market are General Electric, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Toshiba Corporation, Siemens Healthcare GmbH, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., Agilent Technologies Inc., Hologic Inc., Illumina Inc., BioMérieux SA, Bio-Rad Laboratories Inc., Quest Diagnostics Inc., Qiagen N.V., Cepheid, Veracyte Inc., DiaSorin S.p.A., Myriad Genetics Inc., Interpace Biosciences, Guardant Health, BillionToOne, Canon Inc., Beckman Coulter Inc.

Get The Full Thyroid Cancer Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/thyroid-cancer-diagnostics-global-market-report

Which Region Is The Largest In The Thyroid Cancer Diagnostics Market?

North America was the largest region in the thyroid cancer diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyroid cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Thyroid Cancer Diagnostics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/thyroid-cancer-diagnostics-global-market-report

Browse Through More Reports Similar to the Global Thyroid Cancer Diagnostics Market 2026, By The Business Research Company

Thyroid Function Test Market Report 2026

https://www.thebusinessresearchcompany.com/report/thyroid-function-test-global-market-report

Cancer Diagnostics Market Report

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Thyroid Cancer Drugs Market Report

https://www.thebusinessresearchcompany.com/report/thyroid-cancer-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795